Karla Ann Kirkegaard
age ~69
from San Francisco, CA
- Also known as:
-
- Karla A Kirkegaard
- Karla A Sarnow
Karla Kirkegaard Phones & Addresses
- San Francisco, CA
- Fresno, CA
- Lakeshore, CA
- 830 Hamilton Ave, Palo Alto, CA 94301 • 650 328-6307
- Stanford, CA
- Boulder, CO
Work
-
Company:United states
Languages
English
Us Patents
-
Methods Of Identifying Anti-Viral Agents
view source -
US Patent:7476499, Jan 13, 2009
-
Filed:Jun 13, 2007
-
Appl. No.:11/762607
-
Inventors:Karla A. Kirkegaard - Palo Alto CA, US
Scott M. Crowder - San Francisco CA, US -
Assignee:The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
-
International Classification:C12Q 1/70
C12Q 1/18 -
US Classification:435 5, 435 6, 435 71
-
Abstract:The present invention provides methods of identifying candidate anti-viral agents.
-
Inhibitors Of Viral Infection
view source -
US Patent:20020164348, Nov 7, 2002
-
Filed:May 22, 2001
-
Appl. No.:09/863841
-
Inventors:Karla Kirkegaard - Palo Alto CA, US
Kathy Richmond - Mountain View CA, US
John Lyle - Palo Alto CA, US
Steve Schultz - Tsaile AZ, US
Scott Hobson - Schriesheim, DE -
International Classification:A61K039/12
C12Q001/70 -
US Classification:424/186100, 530/388300, 435/005000
-
Abstract:The present invention provides a viral RNA-dependent RNA polymerase pharmacophore which is characterized by binding to a conserved interface binding surfaces of a viral RNA-dependent RNA polymerase.
-
Viral Vectors Useful In Induction Of Humoral Or Cellular Immunity
view source -
US Patent:20040052765, Mar 18, 2004
-
Filed:Sep 2, 2003
-
Appl. No.:10/276752
-
Inventors:Karla Kirkegaard - Palo Alto CA, US
Dana Dodd - Palo Alto CA, US
Stephen Deitz - Redwood City CA, US
John Doedens - Seattle WA, US -
International Classification:A61K048/00
C12N007/00
C12N015/86 -
US Classification:424/093200, 435/456000, 435/235100
-
Abstract:The invention features recombinant viral vectors that take advantage of the activity of picornaviral protein 3A in modulating cytokine secretion and antigen presentation on MHC Class (MHC I), which in turn provides for modulation of a Th1-mediated immune response to the transfected host cell. Specifically, a recombinant viral vector comprising a sequence encoding picornaviral protein 3A provides for decreased antigen presentation on MHC 1 and a decreased incidence of Th1-mediated immune response, while a recombinant picornaviral vector that is deficient in protein 3A production provides for increased cytokine secretion, increased antigen presentation on MHC and increased Th1-mediated immune response towards the transfected host cell. The invention also features methods of inducing humoral or cellular immunity using the vectors.
Resumes
Karla Kirkegaard
view sourceLocation:
830 Hamilton Ave, Palo Alto, CA 94301
Work:
United States
Languages:
English
Youtube
Karla Helle Kirkegaard
view sourceFriends:
Poul Vinholt, Marianne Vind, Asmus Christian Paulsen
Karla Ruiz Kirkegaard
view sourceFriends:
Kelly Walker, Terri Brownlee, Lucas Silsbee, Misti Flores
News
The coronavirus isn’t alive. That’s why it’s so hard to kill.
view source- For this reason, antiviral drugs must be extremely targeted and specific, said Stanford virologist Karla Kirkegaard. They tend to target proteins produced by the virus (using our cellular machinery) as part of its replication process. These proteins are unique to their viruses. This means the drugs
- Date: Mar 23, 2020
- Category: Health
- Source: Google
Stanford to develop next-gen vaccines with $50M grant from Gates foundation
view source- achford and Carlota A. Harris Professor, also in the Department of Microbiology and Immunology; Atul Butte, associate professor of pediatrics and genetics and, by courtesy, computer science; Yvonne Maldonado, professor of pediatrics and of health policy and research; Karla Kirkegaard, the Violetta L.
- Date: Jan 31, 2015
- Category: Health
- Source: Google
MIT Scientists Develop a Drug to Fight Any Viral Infection
view source- "Viruses are pretty good at developing resistance to things we try against them, but in this case, it's hard to think of a simple pathway to drug resistance," said Karla Kirkegaard, professor of microbiology and immunology at Stanford University.
- Date: Aug 11, 2011
- Category: Health
- Source: Google
New drug could cure nearly any viral infection
view source- Combining those two elements is a great idea and a very novel approach, says Karla Kirkegaard, professor of microbiology and immunology at Stanford University. Viruses are pretty good at developing resistance to things we try against them, but in this case, its hard to think of a simple pathway
- Date: Aug 09, 2011
- Category: Health
- Source: Google
Classmates
Bullard High School, Fres...
view sourceGraduates:
Lisa Chambers (1987-1991),
Karla Kirkegaard (1969-1972),
Armine Sargsyan (1997-2001),
Karla Allred (1984-1988)
Karla Kirkegaard (1969-1972),
Armine Sargsyan (1997-2001),
Karla Allred (1984-1988)
Googleplus
Karla Kirkegaard
Get Report for Karla Ann Kirkegaard from San Francisco, CA, age ~69